Picture of Zhaoke Ophthalmology logo

6622 — Zhaoke Ophthalmology News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Brief: Zhaoke Ophthalmology Got U.S. FDA Acceptance Of New Drug Application For Nvk002

June 7 (Reuters) - Zhaoke Ophthalmology Ltd  6622.HK :
    * U.S. FDA ACCEPTANCE OF NEW DRUG APPLICATION FOR NVK002 FOR
TREATMENT OF MYOPIA PROGRESSION

Further company coverage:  6622.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Zhaoke Ophthalmology

See all news